Annual Revenue
$86.69 M
+$63.16 M+268.50%
September 30, 2024
Summary
- As of February 24, 2025, HQL annual revenue is $86.69 million, with the most recent change of +$63.16 million (+268.50%) on September 30, 2024.
- During the last 3 years, HQL annual revenue has risen by +$21.00 million (+31.96%).
- HQL annual revenue is now at all-time high.
Performance
HQL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- HQL quarterly revenue is not available.
Performance
HQL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- HQL TTM revenue is not available.
Performance
HQL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
HQL Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +268.5% | - | - |
3 y3 years | +32.0% | - | - |
5 y5 years | - | - | - |
HQL Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +184.0% | ||||
5 y | 5-year | at high | +184.0% | ||||
alltime | all time | at high | +184.0% |
Tekla Life Sciences Investors Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | $86.69 M(+268.5%) | - | - |
Sep 2023 | $23.52 M(-122.8%) | - | - |
Sep 2022 | -$103.25 M(-257.2%) | - | - |
Sep 2021 | $65.69 M | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | $2.18 M(+65.9%) | $3.49 M(+165.9%) |
Sep 2019 | - | $1.31 M(>+9900.0%) | $1.31 M(+32.9%) |
Mar 2019 | - | $0.00(-100.0%) | $988.76 K(0.0%) |
Sep 2018 | - | $988.76 K | $988.76 K |
FAQ
- What is Tekla Life Sciences Investors annual revenue?
- What is the all time high annual revenue for Tekla Life Sciences Investors?
- What is Tekla Life Sciences Investors annual revenue year-on-year change?
- What is the all time high quarterly revenue for Tekla Life Sciences Investors?
- What is the all time high TTM revenue for Tekla Life Sciences Investors?
What is Tekla Life Sciences Investors annual revenue?
The current annual revenue of HQL is $86.69 M
What is the all time high annual revenue for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high annual revenue is $86.69 M
What is Tekla Life Sciences Investors annual revenue year-on-year change?
Over the past year, HQL annual revenue has changed by +$63.16 M (+268.50%)
What is the all time high quarterly revenue for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high quarterly revenue is $2.18 M
What is the all time high TTM revenue for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high TTM revenue is $3.49 M